These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35474453)

  • 21. A look into the link between centrosome amplification and breast cancer.
    Zhang Y; Tian J; Qu C; Peng Y; Lei J; Sun L; Zong B; Liu S
    Biomed Pharmacother; 2020 Dec; 132():110924. PubMed ID: 33128942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin.
    Brouwer NJ; Konstantinou EK; Gragoudas ES; Marinkovic M; Luyten GPM; Kim IK; Jager MJ; Vavvas DG
    Invest Ophthalmol Vis Sci; 2021 Apr; 62(4):3. PubMed ID: 33798262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting primary and metastatic uveal melanoma with a G protein inhibitor.
    Onken MD; Makepeace CM; Kaltenbronn KM; Choi J; Hernandez-Aya L; Weilbaecher KN; Piggott KD; Rao PK; Yuede CM; Dixon AJ; Osei-Owusu P; Cooper JA; Blumer KJ
    J Biol Chem; 2021; 296():100403. PubMed ID: 33577798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of microRNA-130a represses uveal melanoma cell migration and invasion through inactivation of the Wnt/β-catenin signaling pathway by downregulating USP6.
    Wu S; Han M; Zhang C
    Cancer Gene Ther; 2022 Jul; 29(7):930-939. PubMed ID: 34522027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skewed expression of the genes encoding epigenetic modifiers in high-risk uveal melanoma.
    Herlihy N; Dogrusöz M; van Essen TH; Harbour JW; van der Velden PA; van Eggermond MC; Haasnoot GW; van den Elsen PJ; Jager MJ
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(3):1447-58. PubMed ID: 25593028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Prognostic Value of AJCC Staging in Uveal Melanoma Is Enhanced by Adding Chromosome 3 and 8q Status.
    Dogrusöz M; Bagger M; van Duinen SG; Kroes WG; Ruivenkamp CA; Böhringer S; Andersen KK; Luyten GP; Kiilgaard JF; Jager MJ
    Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):833-842. PubMed ID: 28159971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Germline MBD4 Mutations and Predisposition to Uveal Melanoma.
    Derrien AC; Rodrigues M; Eeckhoutte A; Dayot S; Houy A; Mobuchon L; Gardrat S; Lequin D; Ballet S; Pierron G; Alsafadi S; Mariani O; El-Marjou A; Matet A; Colas C; Cassoux N; Stern MH
    J Natl Cancer Inst; 2021 Jan; 113(1):80-87. PubMed ID: 32239153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRD4-targeted therapy induces Myc-independent cytotoxicity in Gnaq/11-mutatant uveal melanoma cells.
    Ambrosini G; Sawle AD; Musi E; Schwartz GK
    Oncotarget; 2015 Oct; 6(32):33397-409. PubMed ID: 26397223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA expression analysis and Multiplex ligation-dependent probe amplification in metastatic and non-metastatic uveal melanoma.
    Larsen AC; Holst L; Kaczkowski B; Andersen MT; Manfé V; Siersma VD; Kolko M; Kiilgaard JF; Winther O; Prause JU; Gniadecki R; Heegaard S
    Acta Ophthalmol; 2014 Sep; 92(6):541-9. PubMed ID: 24373459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
    Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA
    Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Six-gene-based prognostic model predicts overall survival in patients with uveal melanoma.
    Wan Q; Tang J; Lu J; Jin L; Su Y; Wang S; Cheng Y; Liu Y; Li C; Wang Z
    Cancer Biomark; 2020; 27(3):343-356. PubMed ID: 31903983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG-1 metastasis markers and leads to the identification of DJ-1 as a potential serum biomarker.
    Pardo M; García A; Thomas B; Piñeiro A; Akoulitchev A; Dwek RA; Zitzmann N
    Int J Cancer; 2006 Sep; 119(5):1014-22. PubMed ID: 16570276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours.
    Johansson PA; Brooks K; Newell F; Palmer JM; Wilmott JS; Pritchard AL; Broit N; Wood S; Carlino MS; Leonard C; Koufariotis LT; Nathan V; Beasley AB; Howlie M; Dawson R; Rizos H; Schmidt CW; Long GV; Hamilton H; Kiilgaard JF; Isaacs T; Gray ES; Rolfe OJ; Park JJ; Stark A; Mann GJ; Scolyer RA; Pearson JV; van Baren N; Waddell N; Wadt KW; McGrath LA; Warrier SK; Glasson W; Hayward NK
    Nat Commun; 2020 May; 11(1):2408. PubMed ID: 32415113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elucidating the role of the FoxO3a transcription factor in the IGF-1-induced migration and invasion of uveal melanoma cancer cells.
    Yan F; Liao R; Farhan M; Wang T; Chen J; Wang Z; Little PJ; Zheng W
    Biomed Pharmacother; 2016 Dec; 84():1538-1550. PubMed ID: 27881235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monosomy 3 Influences Epithelial-Mesenchymal Transition Gene Expression in Uveal Melanoma Patients; Consequences for Liquid Biopsy.
    Soltysova A; Sedlackova T; Dvorska D; Jasek K; Chokhachi Baradaran P; Horvathova Kajabova V; Demkova L; Buocikova V; Kurucova T; Lyskova D; Furdova A; Minarik G; Babal P; Dankova Z; Smolkova B
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Long-term Serial Passaging on the Characteristics and Properties of Cell Lines Derived From Uveal Melanoma Primary Tumors.
    Mouriaux F; Zaniolo K; Bergeron MA; Weidmann C; De La Fouchardière A; Fournier F; Droit A; Morcos MW; Landreville S; Guérin SL
    Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5288-5301. PubMed ID: 27723895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of formalin-fixed and snap-frozen samples analyzed by multiplex ligation-dependent probe amplification for prognostic testing in uveal melanoma.
    Lake SL; Kalirai H; Dopierala J; Damato BE; Coupland SE
    Invest Ophthalmol Vis Sci; 2012 May; 53(6):2647-52. PubMed ID: 22427594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterisation of novel uveal melanoma cell lines under serum-free conditions.
    Suesskind D; Gauss S; Faust UE; Bauer P; Schrader M; Bartz-Schmidt KU; Henke-Fahle S
    Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):2063-70. PubMed ID: 23456173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
    Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
    Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of legumain in uveal melanoma.
    Wu T; Sun L; Wu Y; Xiang R; Li Y; Rong W; Sun F; Wang N
    Mol Med Rep; 2016 Mar; 13(3):2377-84. PubMed ID: 26846877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.